Rchr
J-GLOBAL ID：202301012419892382
Update date: Jun. 04, 2024
Han Min
カン ビン | Han Min
Affiliation and department：
Papers (5)：
-
Xuan Wen, Min Han, Masaki Hosoya, Rika Toshima, Mai Onishi, Tomoaki Fujii, Shigeo Yamaguchi, Shunsuke Kato. Identification of BRAF Inhibitor Resistance-associated lncRNAs Using Genome-scale CRISPR-Cas9 Transcriptional Activation Screening. Anticancer research. 2024. 44. 6. 2349-2358
-
MAI ONISHI, SHIGEO YAMAGUCHI, XUAN WEN, MIN HAN, HIDENORI KIDO, TOMOYUKI ARUGA, SHIN-ICHIRO HORIGUCHI, SHUNSUKE KATO. TP53Signature Score Predicts Prognosis and Immune Response in Triple-negative Breast Cancer. Anticancer Research. 2023. 43. 4. 1731-1739
-
MIN HAN, SHIGEO YAMAGUCHI, MAI ONISHI, TOMOAKI FUJII, MASAKI HOSOYA, XUAN WEN, HIDENORI KIDO, SHUNSUKE KATO. The MDM2 and CDKN2A Copy-number-variation Influence the TP53-signature-score in Wild-type TP53 Luminal Type Breast Cancer. Anticancer Research. 2022. 42. 5. 2277-2288
-
Kazuya Takakuwa, Kaoru Mogushi, Min Han, Tomoaki Fujii, Masaki Hosoya, Arina Yamanami, Tomomi Akita, Chikamasa Yamashita, Tetsu Hayashida, Shunsuke Kato, et al. A novel diagnostic system to evaluate epidermal growth factor receptor impact as a prognostic and therapeutic indicator for lung adenocarcinoma. Scientific Reports. 2020. 10. 1
-
Shigeo Yamaguchi, Tomoaki Fujii, Yuki Izumi, Yuki Fukumura, Min Han, Hideki Yamaguchi, Tomomi Akita, Chikamasa Yamashita, Shunsuke Kato, Takao Sekiya. Identification and characterization of a novel adenomatous polyposis coli mutation in adult pancreatoblastoma. Oncotarget. 2018. 9. 12. 10818-10827
Professional career (1)：
Return to Previous Page
